Literature DB >> 17603076

Structural model of the R state of Escherichia coli aspartate transcarbamoylase with substrates bound.

Jie Wang1, Joby Eldo, Evan R Kantrowitz.   

Abstract

The allosteric enzyme aspartate transcarbamoylase (ATCase) exists in two conformational states. The enzyme, in the absence of substrates is primarily in the low-activity T state, is converted to the high-activity R state upon substrate binding, and remains in the R state until substrates are exhausted. These conformational changes have made it difficult to obtain structural data on R-state active-site complexes. Here we report the R-state structure of ATCase with the substrate Asp and the substrate analog phosphonoactamide (PAM) bound. This R-state structure represents the stage in the catalytic mechanism immediately before the formation of the covalent bond between the nitrogen of the amino group of Asp and the carbonyl carbon of carbamoyl phosphate. The binding mode of the PAM is similar to the binding mode of the phosphonate moiety of N-(phosphonoacetyl)-l-aspartate (PALA), the carboxylates of Asp interact with the same residues that interact with the carboxylates of PALA, although the position and orientations are shifted. The amino group of Asp is 2.9 A away from the carbonyl oxygen of PAM, positioned correctly for the nucleophilic attack. Arg105 and Leu267 in the catalytic chain interact with PAM and Asp and help to position the substrates correctly for catalysis. This structure fills a key gap in the structural determination of each of the steps in the catalytic cycle. By combining these data with previously determined structures we can now visualize the allosteric transition through detailed atomic motions that underlie the molecular mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603076      PMCID: PMC2720131          DOI: 10.1016/j.jmb.2007.06.011

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

1.  Insights into the mechanisms of catalysis and heterotropic regulation of Escherichia coli aspartate transcarbamoylase based upon a structure of the enzyme complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate at 2.1 A.

Authors:  L Jin; B Stec; W N Lipscomb; E R Kantrowitz
Journal:  Proteins       Date:  1999-12-01

2.  Direct observation in solution of a preexisting structural equilibrium for a mutant of the allosteric aspartate transcarbamoylase.

Authors:  Luc Fetler; Evan R Kantrowitz; Patrice Vachette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

Review 3.  Automated docking of flexible ligands: applications of AutoDock.

Authors:  D S Goodsell; G M Morris; A J Olson
Journal:  J Mol Recognit       Date:  1996 Jan-Feb       Impact factor: 2.137

4.  Three-dimensional structure of carbamoyl phosphate and succinate bound to aspartate carbamoyltransferase.

Authors:  J E Gouaux; W N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Kinetic mechanism of native Escherichia coli aspartate transcarbamylase.

Authors:  Y Hsuanyu; F C Wedler
Journal:  Arch Biochem Biophys       Date:  1987-12       Impact factor: 4.013

6.  A unifying concept for the active site region in aspartate transcarbamylase.

Authors:  E Heyde
Journal:  Biochim Biophys Acta       Date:  1976-11-08

7.  Superproduction and rapid purification of Escherichia coli aspartate transcarbamylase and its catalytic subunit under extreme derepression of the pyrimidine pathway.

Authors:  S F Nowlan; E R Kantrowitz
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

8.  Quaternary structure changes in aspartate transcarbamylase studied by X-ray solution scattering. Signal transmission following effector binding.

Authors:  G Hervé; M F Moody; P Tauc; P Vachette; P T Jones
Journal:  J Mol Biol       Date:  1985-09-05       Impact factor: 5.469

9.  The catalytic mechanism of Escherichia coli aspartate carbamoyltransferase: a molecular modelling study.

Authors:  J E Gouaux; K L Krause; W N Lipscomb
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

10.  In the presence of CTP, UTP becomes an allosteric inhibitor of aspartate transcarbamoylase.

Authors:  J R Wild; S J Loughrey-Chen; T S Corder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  7 in total

1.  The pathway of product release from the R state of aspartate transcarbamoylase.

Authors:  Kimberly R Mendes; Evan R Kantrowitz
Journal:  J Mol Biol       Date:  2010-07-08       Impact factor: 5.469

2.  Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.

Authors:  Bobby G Ng; Lynne A Wolfe; Mie Ichikawa; Thomas Markello; Miao He; Cynthia J Tifft; William A Gahl; Hudson H Freeze
Journal:  Hum Mol Genet       Date:  2015-02-12       Impact factor: 6.150

3.  Dissecting enzyme regulation by multiple allosteric effectors: nucleotide regulation of aspartate transcarbamoylase.

Authors:  Joshua D Rabinowitz; Jennifer J Hsiao; Kimberly R Gryncel; Evan R Kantrowitz; Xiao-Jiang Feng; Genyuan Li; Herschel Rabitz
Journal:  Biochemistry       Date:  2008-05-03       Impact factor: 3.162

4.  Submicromolar phosphinic inhibitors of Escherichia coli aspartate transcarbamoylase.

Authors:  Laëtitia Coudray; Evan R Kantrowitz; Jean-Luc Montchamp
Journal:  Bioorg Med Chem Lett       Date:  2008-12-06       Impact factor: 2.823

5.  The first high pH structure of Escherichia coli aspartate transcarbamoylase.

Authors:  Kimberly A Stieglitz; Jiarong Xia; Evan R Kantrowitz
Journal:  Proteins       Date:  2009-02-01

6.  Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.

Authors:  Laëtitia Coudray; Anne F Pennebaker; Jean-Luc Montchamp
Journal:  Bioorg Med Chem       Date:  2009-09-30       Impact factor: 3.641

7.  Statistical Mechanics of Allosteric Enzymes.

Authors:  Tal Einav; Linas Mazutis; Rob Phillips
Journal:  J Phys Chem B       Date:  2016-04-29       Impact factor: 2.991

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.